These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21183417)

  • 1. Effect of previous statin use on the incidence of sustained ventricular tachycardia and ventricular fibrillation in patients presenting with acute coronary syndrome.
    Ozaydın M; Türker Y; Erdoğan D; Karabacak M; Varol E; Doğan A; Küçüktepe Z; Içli A
    Anadolu Kardiyol Derg; 2011 Feb; 11(1):22-8. PubMed ID: 21183417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Vyas AK; Guo H; Moss AJ; Olshansky B; McNitt SA; Hall WJ; Zareba W; Steinberg JS; Fischer A; Ruskin J; Andrews ML;
    J Am Coll Cardiol; 2006 Feb; 47(4):769-73. PubMed ID: 16487843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of prior statin therapy on arrhythmic events in patients with acute coronary syndromes (from the Global Registry of Acute Coronary Events [GRACE]).
    Vedre A; Gurm HS; Froehlich JB; Kline-Rogers E; Montalescot G; Gore JM; Brieger D; Quill AL; Eagle KA;
    Am J Cardiol; 2009 Dec; 104(12):1613-7. PubMed ID: 19962463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of statin therapy on ventricular tachyarrhythmias: a meta-analysis.
    Wanahita N; Chen J; Bangalore S; Shah K; Rachko M; Coleman CI; Schweitzer P
    Am J Ther; 2012 Jan; 19(1):16-23. PubMed ID: 20720485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac arrhythmias in Thai Acute Coronary Syndrome Registry.
    Ngarmukos T; Sriratanasthavorn C; Sansaneevithayakul B; Kasemsuwan P; Angkasuwapala K; Yamwong S
    J Med Assoc Thai; 2007 Oct; 90 Suppl 1():58-64. PubMed ID: 18431887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of early and intensive statin therapy on ventricular premature beat or non-sustained ventricular tachycardia in patients with acute coronary syndrome.
    He XZ; Zhou SH; Wan XH; Wang HY; Zhong QH; Xue JF
    Cardiol J; 2010; 17(4):381-5. PubMed ID: 20690094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin therapy significantly reduces risk of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.
    Jacob S; Manickam P; Rathod A; Badheka A; Afonso L; Aravindhakshan R
    Am J Ther; 2012 Jul; 19(4):261-8. PubMed ID: 21048429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Gibson CM; Pride YB; Buros JL; Lord E; Shui A; Murphy SA; Pinto DS; Zimetbaum PJ; Sabatine MS; Cannon CP; Josephson ME;
    J Am Coll Cardiol; 2008 Feb; 51(5):546-51. PubMed ID: 18237683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes.
    Piccini JP; White JA; Mehta RH; Lokhnygina Y; Al-Khatib SM; Tricoci P; Pollack CV; Montalescot G; Van de Werf F; Gibson CM; Giugliano RP; Califf RM; Harrington RA; Newby LK
    Circulation; 2012 Jul; 126(1):41-9. PubMed ID: 22645292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes.
    Mehta RH; Harjai KJ; Grines L; Stone GW; Boura J; Cox D; O'Neill W; Grines CL;
    J Am Coll Cardiol; 2004 May; 43(10):1765-72. PubMed ID: 15145097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and the reduction of sudden cardiac death: antiarrhythmic or anti-ischemic effect?
    Beri A; Contractor T; Khasnis A; Thakur R
    Am J Cardiovasc Drugs; 2010; 10(3):155-64. PubMed ID: 20524717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocautery-induced ventricular tachycardia and fibrillation during device implantation and explantation.
    Lo R; Mitrache A; Quan W; Cohen TJ
    J Invasive Cardiol; 2007 Jan; 19(1):12-5. PubMed ID: 17297178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of nonsustained and sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.
    Zhou X; Gunderson BD; Olson WH;
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):14-20. PubMed ID: 15028067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term incidence of malignant ventricular arrhythmia and shock therapy in patients with primary defibrillator implantation does not differ from event rates in patients treated for survived cardiac arrest.
    Backenköhler U; Erdogan A; Steen-Mueller MK; Kuhlmann C; Most A; Schaefer C; Stertmann W; Waas W; Tillmanns H; Waldecker B
    J Cardiovasc Electrophysiol; 2005 May; 16(5):478-82. PubMed ID: 15877617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study.
    Albert CM; Rosenthal L; Calkins H; Steinberg JS; Ruskin JN; Wang P; Muller JE; Mittleman MA;
    J Am Coll Cardiol; 2007 Dec; 50(23):2233-40. PubMed ID: 18061071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnitude and prognosis associated with ventricular arrhythmias in patients hospitalized with acute coronary syndromes (from the GRACE Registry).
    Avezum A; Piegas LS; Goldberg RJ; Brieger D; Stiles MK; Paolini R; Huang W; Gore JM;
    Am J Cardiol; 2008 Dec; 102(12):1577-82. PubMed ID: 19064008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II).
    Andersen M; Videbaek R; Boesgaard S; Sander K; Hansen PB; Gustafsson F
    J Heart Lung Transplant; 2009 Jul; 28(7):733-5. PubMed ID: 19560703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T
    Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.